CAS: 75178-87-9; Tert-Butyl (4-Hydroxybutyl)Carbamate

该化合物是一种化学化合物,其特点是,在丁醇链上的氨基生物组中,存在一种亚丁-丁氧碳基(Boc)保护组,该化合物一般是无色的,根据纯度和形态,无色的黄色液体或固态,可溶于极地有机溶剂,在各种合成应用中有用,特别是在有机化学和浸泡合成中.Boc组是氨基生物组的一个保护性协会,可以有选择地作出反应,而不会干扰矿的功能.该化合物经常用于合成药物和生物活性分子,因此有必要对氨基生物活性分子进行控制释放.此外,该化合物在标准实验室条件下可能表现出中度稳定,但应当谨慎处理,因为有很强的酸或碱基具有潜在的再活动.

结构式图片

相似化合物

13325-10-5 42042-68-2 99207-32-6

欧盟法规

C&L通报

上下游产品

CAS号13325-10-5 4-氨基-1-丁醇 | CAS号24424-99-5 二碳酸二叔丁酯 | CAS号85909-08-6 N-B°C-2-吡咯烷酮 | CAS号2508-29-4 5-氨基-1-戊醇 | CAS号57294-38-9 N-B°C-γ-氨基丁酸 | CAS号104700-36-9 ethyl (2E)-4-((... | CAS号67-56-1 甲醇 | CAS号67-63-0 异丙醇 | CAS号33545-98-1 B°C-1,4-丁二胺盐酸盐 | CAS号262278-40-0 (4-碘丁基)氨基甲酸叔丁酯 | CAS号85909-08-6 N-B°C-2-吡咯烷酮 | CAS号68076-36-8 N-(叔丁氧羰基)-1,4-丁二胺 | CAS号129392-85-4 (4-叠氮丁基)氨基甲酸叔丁酯 | CAS号174626-25-6 4-[(2-methylpro... | CAS号164365-88-2 4-(B°C-氨基)丁基溴 | CAS号73286-71-2 N-B°C-2-吡咯啉 | CAS号68076-40-4 tert-butyl N-[4... | CAS号84766-90-5 N-(4-氧代丁基)氨基甲酸叔丁酯

合成工艺路线路线简述

    4-氨基-1-丁醇置于三乙胺体系中,用76%的收率获得产物4-(N-叔丁氧羰基氨基)-1-丁醇
    参考文献:Target Protein Eed Degradation-Inducing Degraducer,Preparation Method Thereof,And Pharmaceutical Composition For Preventing Or Treating Diseases Related To Eed,Ezh2,Or Prc2,Comprising Same As Active Ingredient
    标题:Target Protein Eed Degradation-Inducing Degraducer,Preparation Method Thereof,And Pharmaceutical Composition For Preventing Or Treating Diseases Related To Eed,Ezh2,Or Prc2,Comprising Same As Active Ingredient
    摘要:本发明涉及一种靶蛋白降解诱导剂degraducer,其制备方法以及包含其作为活性成分的用于预防或治疗与eed,Ezh2或prc2相关疾病的药物组合物.根据本发明,由式1表示的一种新化合物是一种degraducer化合物,通过利用cereblon E3泛素连接酶,Von Hippel-Lindau肿瘤抑制因子(vhl)e3泛素连接酶,鼠双分钟2同源物(mdm2)e3泛素连接酶和细胞凋亡抑制蛋白1(ciap)e3泛素连接酶诱导靶蛋白,即胚胎外胚层发育(eed)或多能复合体抑制2(prc2)的降解,其中该化合物通过泛素蛋白酶体系统(ups)显著实现靶蛋白降解诱导活性的方面,因此可以提供一种用于预防或治疗与靶蛋白相关疾病或症状的药物组合物,以及包含所述化合物作为活性成分的功能性保健食品组合物,具有有益效果.

    海关参考信息

    专利信息


    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-12337036-B2
    优先权日:2018-01-01
    标题:Compounds and methods for trans-membrane delivery of molecules
    发明人:ZIV ILAN; GRIMBERG HAGIT; DUBROVSKY JOSEPH
    权利人:APOSENSE LTD
    摘要:The Invention provides a novel delivery system for delivery of drugs across biological membranes. It provides novel chemical conjugates that comprise said delivery system, methods for synthesis of said compounds, and methods for utilization of said delivery system, among others, for delivery of genetic drugs into tissues and cells, in vitro, ex vivo, and in vivo, for the treatment of various medical disorders.

    专利号:US-12441733-B2
    优先权日:2018-03-26
    标题:Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors
    发明人:ARISTA LUCA; HEBACH CHRISTINA; HOLLINGWORTH GREGORY JOHN; HOLZER PHILIPP; IMBACH-WEESE PATRICIA; LORBER JULIEN; MACHAUER RAINER; SCHMIEDEBERG NIKO; VULPETTI ANNA; ZOLLER THOMAS
    权利人:NOVARTIS AG
    摘要:The invention relates to compounds of the formulae (I), (III), (IIIa), (XXIa), (XXIII), and/or (XLVI)or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.

    专利号:WO-2024216075-A1
    优先权日:2023-04-13
    标题 :Synthesis of mavorixafor and intermediates thereof
    发明人:SEKIRNIK ANGELINA ROBERTA; TAVERAS ART; GAO FENG; ZHAO ZHIGANG
    权利人:X4 PHARMACEUTICALS INC
    摘要:The present invention relates to methods for synthesizing C-X-C receptor type 4 (CXCR4) inhibitor mavorixafor and to intermediates thereto.

    专利号:US-7491727-B2
    优先权日:2003-01-31
    标题:Arylpiperazinyl compounds
    发明人:DHANOA DALE S; CHEN DONGLI; BECKER OREN; NOIMAN SILVIA; CHERUKU SRINIVASA R; MARANTZ YAEL; SHARADENDU ANURAG; SHACHAM SHARON; HEIFETZ ALEXANDER; MOHANTY PRADYUMNA; INBAL BOAZ; FICHMAN MERAV; NUDELMAN RAPHAEL; BAR-HAIM SHAY
    权利人:EPIX DELAWARE INC
    摘要:The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formula I, and synthesis and uses thereof for treating diseases including those mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
    北京偶合科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ouhechem.com
    企业联系电话:010-51280831(不占线);010-82967028👤
    📞北京偶合科技有限公司 ⚠️参考联系方式
    联系人:刘先生
    电话:010-51280831(不占线);010-82967028
    手机:13911808554
    传真:010-82967029
    邮箱:sales@ouhechem.com
    通信地址: 北京市海淀区西三旗桥东上奥世纪2b-1328室
    邮编: 100096
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三旗桥东上奥世纪2b-1328室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1055/s-2008-1072736
    摘要:Cossy J, Sieng B, Ventura O, Bellosta V. A Convergent Total Synthesis of (+)-Febrifugine. Synlett. 2008 May;2008(8):1216–8. doi: 10.1055/s-2008-1072736.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知